Weidmann P, Böhlen L, de Courten M
Medical Polyclinic, University of Berne, Switzerland.
J Hypertens Suppl. 1995 Aug;13(2):S65-72. doi: 10.1097/00004872-199508001-00010.
Insulin resistance and reactive hyperinsulinemia occur not only with obesity, impaired glucose tolerance or non-insulin-dependent (type 2) diabetes mellitus, but also in many non-obese, non-diabetic patients with essential hypertension and their currently normotensive, lean, young offspring, as well as in some other conditions known to promote hypertension. Insulin resistance impairs glucose tolerance, while insulin resistance and/or hyperinsulinemia promote dyslipidemia, body fat deposition and probably atherogenesis. Therefore, the common coexistence of a genetic predisposition for hypertension with insulin resistance helps to explain the frequent, although temporally often dissociated, occurrence of hypertension together with dyslipidemia, obesity and type 2 diabetes in a given patient. INSULIN RESISTANCE AND HYPERINSULINEMIA AS SLOW PRESSOR MECHANISMS: In the pathogenesis of hypertension, inappropriate vasoconstriction (due to an imbalance of vasoactive substances and/or raised cytosolic calcium) and/or structural vasculopathy is particularly important. Among the mosaic of assumed pressor mechanisms, distinct Na+ retention is almost invariably involved in diabetes mellitus, while sympathetic activation tends to occur in essential hypertension, particularly in association with obesity. Insulin resistance may develop as a consequence of an intracellular excess of Ca2+ or a decrease in Mg2+, an impaired insulin-mediated rise in skeletal muscle blood flow, increased sympathetic activity or excess body weight. Acute hyperinsulinemia causes arterial vasodilation on one hand and increases sympathetic activity and renal Na+ reabsorption on the other. Chronically, hyperinsulinemia may promote cardiovascular muscle cell proliferation and atherogenesis, while insulin resistance may be associated with certain transmembraneous cation transporters, leading to an increase in cytosolic Ca2+. Hyperinsulinemia and/or insulin resistance may also be associated with an increased blood pressure sensitivity to high salt intake. In the mosaic of many different blood pressure-raising mechanisms, insulin resistance and/or hyperinsulinemia is likely to represent an amplifying slow or very slow pressor factor.
胰岛素抵抗和反应性高胰岛素血症不仅见于肥胖、糖耐量受损或非胰岛素依赖型(2型)糖尿病患者,也见于许多非肥胖、非糖尿病的原发性高血压患者及其目前血压正常、体型偏瘦的年轻后代,以及其他一些已知会促进高血压发生的情况。胰岛素抵抗损害糖耐量,而胰岛素抵抗和/或高胰岛素血症会促进血脂异常、体脂沉积以及可能的动脉粥样硬化形成。因此,高血压的遗传易感性与胰岛素抵抗共同存在,有助于解释在特定患者中高血压为何常常与血脂异常、肥胖和2型糖尿病同时出现,尽管它们在时间上常常不相关联。
在高血压的发病机制中,不适当的血管收缩(由于血管活性物质失衡和/或胞浆钙升高)和/或结构性血管病变尤为重要。在众多假定的升压机制中,明显的钠潴留几乎总是与糖尿病有关,而交感神经激活往往发生在原发性高血压中,尤其是与肥胖相关时。胰岛素抵抗可能是由于细胞内钙过量或镁减少、胰岛素介导的骨骼肌血流增加受损、交感神经活动增加或体重超标所致。急性高胰岛素血症一方面导致动脉血管舒张,另一方面增加交感神经活动和肾脏对钠的重吸收。长期来看,高胰岛素血症可能促进心血管肌细胞增殖和动脉粥样硬化形成,而胰岛素抵抗可能与某些跨膜阳离子转运体有关,导致胞浆钙增加。高胰岛素血症和/或胰岛素抵抗也可能与高盐摄入时血压敏感性增加有关。在许多不同的血压升高机制中,胰岛素抵抗和/或高胰岛素血症可能是一个放大的缓慢或非常缓慢的升压因素。